The Carlyle Group Inc. 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-28 4:30 pm Unchanged | 2025-08-28 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Carlyle Group Inc. CG | 3,496,808 4.900% | 0 (Unchanged) | Filing |
| 2024-02-12 4:36 pm Purchase | 2023-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Carlyle Group Inc. CG | 3,496,808 6.100% | 561,702 (+19.14%) | Filing |
| 2023-03-09 4:17 pm Purchase | 2023-03-01 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Carlyle Group Inc. CG | 2,935,106 6.700% | 2,935,106 (New Position) | Filing |